91215-17-7

• 常用中文名：(4,5-二氢-2-噻唑)-苯乙胺
• 常用英文名：(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-4-INDANYLAMINE
• CAS号：91215-17-7
• 分子式：C₁₁H₁₄N₂S
• 分子量：206.30700
• 发布时间：2018-12-27 14:56:39
• 更新时间：2025-08-26 18:11:11

名称

• 中文名: (4,5-二氢-2-噻唑)-苯乙胺
• 英文名: N-(2-Phenylethyl)-4,5-dihydro-1,3-thiazol-2-amine
• 英文别名: (4,5-Dihydro-thiazol-2-yl)-phenethyl-amine; HMS1408N14; phenethylamino-2 dihydro-4,5 thiazole; 2-<2-Phenyl-ethylamino>-thiazolin

物化性质

• 密度: 1.16g/cm3
• 沸点: 349.4ºC at 760 mmHg
• 分子式: C₁₁H₁₄N₂S
• 分子量: 206.30700
• 闪点: 165.1ºC
• 精确质量: 206.08800
• PSA: 49.69000
• LogP: 2.25030
• 折射率: 1.62
• 储存条件: -20°C

安全

• 海关编码: 2934100090

合成路线

29146-59-6 ~68% 91215-17-7

文献：Caujolle, Raymond; Amarouch, Hamid; Payard, Marc; Loiseau, Philippe R.; Bories, Christian; et al. European Journal of Medicinal Chemistry, 1989 , vol. 24, p. 287 - 292

2257-09-2 ~% 91215-17-7

文献：Caujolle, Raymond; Amarouch, Hamid; Payard, Marc; Loiseau, Philippe R.; Bories, Christian; et al. European Journal of Medicinal Chemistry, 1989 , vol. 24, p. 287 - 292

64-04-0 ~% 91215-17-7

文献：Caujolle, Raymond; Amarouch, Hamid; Payard, Marc; Loiseau, Philippe R.; Bories, Christian; et al. European Journal of Medicinal Chemistry, 1989 , vol. 24, p. 287 - 292

24954-65-2 ~% 91215-17-7

文献：Caujolle, Raymond; Amarouch, Hamid; Payard, Marc; Loiseau, Philippe R.; Bories, Christian; et al. European Journal of Medicinal Chemistry, 1989 , vol. 24, p. 287 - 292

19457-13-7 ~% 91215-17-7

文献：Caujolle, Raymond; Amarouch, Hamid; Payard, Marc; Loiseau, Philippe R.; Bories, Christian; et al. European Journal of Medicinal Chemistry, 1989 , vol. 24, p. 287 - 292

2257-09-2 141-43-5 ~% 91215-17-7

文献：Hirashima, Akinori; Yoshii, Yutaka; Eto, Morifusa Bioscience, Biotechnology, and Biochemistry, 1992 , vol. 56, # 7 p. 1062 - 1065

上下游产品

上游产品  6
29146-59-6 2257-09-2 64-04-0 24954-65-2
19457-13-7 141-43-5
下游产品  0

海关

海关编码	2934100090
中文概述	2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途
Summary	2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%